期刊文献+

腹膜透析患者真菌性腹膜炎的临床特点

下载PDF
导出
摘要 目的探讨腹膜透析(腹透)患者真菌性腹膜炎诊断、治疗和预后特点。方法回顾性分析本中心开展腹透以来资料齐全的真菌性腹膜炎患者的资料,对腹腔真菌感染的菌种分布、危险因素、临床特点、治疗以及转归进行分析。结果14年中本中心真菌性腹膜炎共26例次,占所有腹膜炎发生率的8%。广谱抗生素的应用、前期细菌性腹膜炎、糖尿病可能是真菌性腹膜炎的易感因素。本组患者早期诊断率27%,致病真菌以白色念珠菌为主,占61%。治疗方法为抗真菌药物治疗和及时拔除腹透管、转作血液透析。大部分患者对抗真菌治疗耐受性良好,但单纯抗真菌治疗疗效有限。本组患者病死率30.8%,腹透管拔除率69%,腹透脱落率42.3%。结论腹透患者真菌性腹膜炎发病率较低,但临床预后差,患者病死率和腹透脱落率高。早期诊断,尽早给予抗真菌治疗和根据病情及时拔除腹透管、转为血液透析是控制感染、挽救患者生命的重要环节。
出处 《临床肾脏病杂志》 2005年第1期3-5,共3页 Journal Of Clinical Nephrology
  • 相关文献

参考文献6

  • 1齐慧敏,甘红兵,卢维基.制霉菌素对腹膜透析霉菌性腹膜炎的预防作用[J].中国临床药理学杂志,2002,18(3):182-184. 被引量:6
  • 2Saran R, Goel S, Khanna R. Fungal peritonitis in continuous ambulatory peritoneal dialysis (editorial). Int J Artif Organs,1996, 19 : 441-445.
  • 3Wang AYM. Yu AXY. Li PKT, et al . Factors predicting outcome of fungal peritonitis in peritoneal dialysis: Analysis of a 9-year experience in a single center. Am J Kidney Dis. 2000,36:1183-1192.
  • 4Goldie, SJ , Kiernan-Tridle L, Torres C. et al. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55episodes. Am J Kidney Dis. 1996, 28:86-91.
  • 5Keane WF, Bailie GR, Boeschoten E. et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int.2000.2 : 396-411.
  • 6Troidle L. Gorban-Brennan N. Kliger A, et al. Continuous peritoneal dialysis-associated peritonitis: A review and current Concepts. Seminars in Dialysis.2003, 16:428-437.

二级参考文献12

  • 1[1]Cheng IK, Fang GX, Chan TM, et al. Fungal peritonitis complicating peritoneal dialysis: Report of 27 cases and review of treatment. Q J Med, 1989;71: 407~416.
  • 2[2]Mecliel C. Peritonitis in patients on Peritoneal Dialysis. Am J Nepbrol, 1994;14:113~120.
  • 3[3]Eisenberg ES, Leviton IM, Sceiro R. Fungal peritonitis in patients receiving peritoneal dialysis: Experience with 11 patients and review of the literature. Rev Infect Dis, 1986;8:309~321.
  • 4[4]Rubin J, kirchner K, Walsh D, et al. Peritonitis during continuous ambulatory peritoneal dialysis: A report of 17 cases. Am J Kidney Dis, 1987;10: 361~368.
  • 5[5]Montenegro J, Aguirre R, Gonzalez R, et al. Risk factors and outcome of Candida peritonitis. Petit Dial Int, 1992;12(Suppl.2): 59~61.
  • 6[6]Bemard DB, Levine J, Odelson BA. A continuous ambulatory peritoneal dialysis patient with fungal peritonitis. Semin Dial, 1991;4: 198~202.
  • 7[7]Kerr CM, Perfect JR, Craven PC, et al. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Intern Med,1983;99:334~347.
  • 8[8]Anonymous. Diagnostic and management of peritoneal dialysis.Report of the Working Party of the British Society for Antimicrobial Chemotherapy. Lancet, 1987;1: 845~849.
  • 9[9]Boeschoten EW, Riebia PJ, Strujik DG, et al. Changing antimicrobial resistance in CAPD peritonitis; in La Greca G, Olivares J, Feriani M. (eds): CAPD: A Decade of Experience. Contrib Nphrol. Basel,Karger, 1991:89;87~95.
  • 10[10]Valenti G, Lorenz M, Branchi ML, et al. Abdominal surgery and peritoneal dialysis. Petit Dial Int, 1992;12(Suppl.2): 61~63.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部